[go: up one dir, main page]

Horan et al., 1964 - Google Patents

Use of an anion exchange resin in treatment of two siblings with familial hypercholesterolemia

Horan et al., 1964

Document ID
7925052049292260909
Author
Horan J
DiLuzio N
Etteldorf J
Publication year
Publication venue
The Journal of Pediatrics

External Links

Snippet

Cholestyramine, an insoluble anion exchange resin which absorbs bile acids in theintestine, was given orally to two siblings with familial hypercholesterolemia. A 3 week course of 9 Gm. of the drug each day failed to alter the plasma cholesterol concentration. However, after a 3 …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Similar Documents

Publication Publication Date Title
Cicero et al. Middle and long-term impact of a very low-carbohydrate ketogenic diet on cardiometabolic factors: a multi-center, cross-sectional, clinical study
Simkin Oral zinc sulphate in rheumatoid arthritis
Jones et al. Modification of fat absorption in the digestive tract by the use of an emulsifying agent
Jakobsson et al. Effectiveness of casein hydrolysate feedings in infants with colic
Deller et al. Calcium metabolism and the bones after partial gastrectomy: II. The nature and cause of the bone disorder
Steiner et al. Importance of dietary cholesterol in man
Mellies et al. Plasma and dietary phytosterols in children
MacLennan et al. Vitamin D supplements and 25-hydroxy vitamin D concentrations in the elderly.
Goodman et al. Idiopathic lipemia with secondary xanthomatosis, hepatosplenomegaly, and lipemic retinalis
SHAW et al. Hypervitaminosis A: report of a case in an adult male
Vaisman et al. Nutritional rehabilitation increases resting energy expenditure without affecting protein turnover in patients with cystic fibrosis
Horan et al. Use of an anion exchange resin in treatment of two siblings with familial hypercholesterolemia
Balistreri et al. Serum bile acid response to a test meal stimulus: a sensitive test of ileal function
GRIBETZ et al. Vitamin A poisoning
Parsons Activation of peptic ulcer by nicotinic acid: Report of five cases
Curran et al. Inhibition of cholesterol biosynthesis in man
Dent et al. HEREDITARY PSEUDO-VITAMIN D DEFICIENCY RICKETS:(" Hereditare Pseudo-mangelrachitis")
Robinson et al. High dose pancreatic enzymes in cystic fibrosis.
PAINE et al. The dietary phenylalanine requirements and tolerances of phenylketonuric patients
Spies Some recent advances in nutrition
SNYDER Idiopathic hypercalcemia of infancy
van Binsbergen Nutritional factors in Dutch family medicine: an inventory
Danowski et al. Hypolipidemic effect of chlorophenoxyisobutyrate in adult‐onset diabetes mellitus
Danowski et al. Ethyl chlorophenoxyisobutyrate (CPIB) effects in juvenile‐onset diabetes mellitus
Bower et al. Treatment of idiopathic polyneuritis by a polyunsaturated fatty-acid diet